Screener Summaries Updates Institutions Sign In More Updates › Earnings › LLY Earnings · Apr 30, 2026
Eli Lilly and Company has filed an 8-K to announce its financial results for the first quarter ended March 31, 2026 LLY ELI LILLY & Co
Eli Lilly and Company has filed an 8-K to announce its financial results for the first quarter ended March 31, 2026. This disclosure is a critical event for investors as it provides the latest quarterly performance data necessary to assess the company's growth trajectory and financial health.
More from ELI LILLY & Co Reports Q3 revenue of $24.4B, raises full-year outlook to $91-$92B Oct 29, 2026 Eli Lilly and Company reported second-quarter 2026 financial results on August 5, 2026, announcing a 48%… Aug 5, 2026 Eli Lilly and Company has released its financial results for the quarter and fiscal year ended December 31, 2025 Feb 4, 2026 Eli Lilly and Company has released its financial results for the quarter ended September 30, 2025 Oct 30, 2025 Eli Lilly and Company has released its financial results for the quarter ended June 30, 2025 Aug 7, 2025 All content on this site is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.
Financial data is obtained from public filings and third-party providers and is provided “as-is” without any guarantee of accuracy, completeness, or timeliness.
© 2026 go-intrinsic.com. All rights reserved.
